Clinical trials
Lymphoma, T-Cell, Peripheral trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 4 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Affimed GmbH | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Daiichi Sankyo | 1 |
| Dizal Pharmaceuticals | 1 |
| Incyte Corporation | 1 |
| Karyopharm Therapeutics Inc | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 16 |
| Lymphoma, Non-Hodgkin | 5 |
| Lymphoma, T-Cell, Cutaneous | 4 |
| Recurrence | 4 |
| Hodgkin Disease | 3 |
| Lymphoma, T-Cell | 3 |
| Lymphoma | 2 |
| Lymphoma, Large B-Cell, Diffuse | 2 |
| Lymphoma, Large-Cell, Anaplastic | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.